Study of INBRX-109 in Conventional Chondrosarcoma
Summary
- Eligibility
- for people ages 18-85 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Victoria Wang, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Inhibrx, Inc.
- ID
- NCT04950075
- Phase
- Phase 2 Chondrosarcoma Research Study
- Study Type
- Interventional
- Participants
- Expecting 201 study participants
- Last Updated